Literature DB >> 10721014

Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis.

P A Ubel1, J Richardson, P Menzel.   

Abstract

In a previous paper, it was argued that Societal Value measurement through person trade-off (PTO) elicitation offers a way to include the values of both general public and patients into cost-effectiveness analysis (CEA). It was said that patients' values could be used to estimate the effect that various health care dimensions have on health-related utility and that public values could be used to estimate the Societal Value of these changes in utility. However, this previous proposal still creates opportunities for the public to misvalue the benefit of health care interventions because of bias or misunderstanding about what the health-related utility really is of various illnesses or disabilities. A procedure that combines patient and public values into CEA to partially correct for this bias is suggested in this paper. In addition, it is pointed out that, although Societal Value measurement offers a role for distinctly public preferences in CEA, it still does not answer the question of whose utilities ought to be included in CEA. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 10721014     DOI: 10.1002/(sici)1099-1050(200003)9:2<127::aid-hec500>3.0.co;2-y

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  17 in total

Review 1.  Resource allocation, social values and the QALY: a review of the debate and empirical evidence.

Authors:  David L B Schwappach
Journal:  Health Expect       Date:  2002-09       Impact factor: 3.377

2.  Community involvement in developing policies for genetic testing: assessing the interests and experiences of individuals affected by genetic conditions.

Authors:  Sarah E Gollust; Kira Apse; Barbara P Fuller; Paul Steven Miller; Barbara B Biesecker
Journal:  Am J Public Health       Date:  2005-01       Impact factor: 9.308

3.  The public's priorities in health services.

Authors:  Giora Kaplan; Orna Baron-Epel
Journal:  Health Expect       Date:  2013-04-03       Impact factor: 3.377

4.  Does diabetes have an impact on health-state utility? a study of Asians in Singapore.

Authors:  P Wang; E S Tai; J Thumboo; Hubertus J M Vrijhoef; Nan Luo
Journal:  Patient       Date:  2014       Impact factor: 3.883

5.  Images of illness: how causal claims and racial associations influence public preferences toward diabetes research spending.

Authors:  Sarah E Gollust; Paula M Lantz; Peter A Ubel
Journal:  J Health Polit Policy Law       Date:  2010-12       Impact factor: 2.265

Review 6.  Valuation of health states in the US study to establish disability weights: lessons from the literature.

Authors:  Jürgen Rehm; Ulrich Frick
Journal:  Int J Methods Psychiatr Res       Date:  2010-03       Impact factor: 4.035

7.  Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public.

Authors:  Peter A Ubel; George Loewenstein; Christopher Jepson
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

8.  Willingness to pay for rapid diagnostic tests for the diagnosis and treatment of malaria in southeast Nigeria: ex post and ex ante.

Authors:  Benjamin Sc Uzochukwu; Obinna E Onwujekwe; Nkoli P Uguru; Maduka D Ughasoro; Ogochukwu P Ezeoke
Journal:  Int J Equity Health       Date:  2010-01-15

9.  Evaluating the consequences of rheumatoid arthritis.

Authors:  Björn Sossong; Stefan Felder; Malte Wolff; Klaus Krüger
Journal:  Eur J Health Econ       Date:  2016-07-28

Review 10.  Cost-effectiveness of smoking cessation and the implications for COPD.

Authors:  Michele A Faulkner; Tom L Lenz; Julie A Stading
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.